Skip to content

TMO

Thermo Fisher Scientific Inc.

EBITDA, 2025
$10.5B
YoY, 2025
+0.8%
5-year CAGR
+0.8%
10-year CAGR
+10.1%

EBITDA

EBITDA by fiscal year

PeriodEBITDAYoY
2025$10.5B+0.8%
2024$10.4B+1.8%
2023$10.3B−12.8%
2022$11.8B−6.7%
2021$12.6B+24.7%
2020$10.1B+47.3%
2019$6.9B+13.6%
2018$6.1B+21.2%
2017$5.0B+18.4%
2016$4.2B+4.8%
2015$4.0B−3.9%
2014$4.2B+60.5%
2013$2.6B+5.8%
2012$2.5B+16.8%
2011$2.1B+9.5%
2010$1.9B+9.2%
2009$1.8B−12.7%
2008$2.0B+16.8%
2007$1.7B—